Trial
NCT00529204
Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of California, Davis
Collaborators
Amylin Pharmaceuticals, LLC.; Eli Lilly and Company
Condition
Diabetes Complications
Intervention
exenatide
Why stopped
Lack of recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-06-20